Sort
10,766 grants matching “checkpoint inhibitor”
Post-translational Surveillance of Genome Expression
$233,253Richard Norman Sifers · Baylor College Of Medicine · R01 · FY2007 · DK
Novel biologics platform for targeting tumors driven by intracellular oncoproteins
$232,969Shohei Koide · New York University School Of Medicine · R21 · FY2023 · CA
Targeting heme metabolism to initiate an immune response against breast cancer liver metastasis
$232,955Michelle M Williams · University Of Pittsburgh At Pittsburgh · R00 · FY2025 · CA
Enhancing the Efficacy of T-cells and immunotherapies by precision targeting of Nrf2 using PROTACs
$232,500Kalyani Pyaram · University Of Kansas Medical Center · P20 · FY2025 · GM
Counteracting Resistance through Host-Directed Myxovirus Inhibitors
$232,500Richard K. Plemper · Emory University · R21 · FY2010 · AI
Distinguishing inflammatory Th17 subsets through using an autoimmune Th17-selective inhibitor
$232,500Zhiheng He · Wake Forest University Health Sciences · R21 · FY2022 · AI
Preclinical Evaluation of VAX014 in Combination with Immune Checkpoint Inhibitors
$232,276Matthew Giacalone · Vaxiion Therapeutics, Inc. · R43 · FY2018 · CA
Targeting MUC1-C for the Treatment of Small Cell Lung Cancer Progression
$232,259Donald W. Kufe · Dana-Farber Cancer Inst · R21 · FY2022 · CA
Lung fibrosis impairs tumor immunity and limits immune checkpoint efficacy
$231,870Brett Howard Herzog · Washington University · K08 · FY2024 · CA
Lung fibrosis impairs tumor immunity and limits immune checkpoint efficacy
$231,870Brett Howard Herzog · Washington University · K08 · FY2025 · CA
Novel small-molecule inhibitors of Wee1 kinase for medulloblastoma treatment
$231,750Philip Reigan · University Of Colorado Denver · R21 · FY2013 · NS
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
$231,701Jonathan Maybaum · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Flow Cytometry Core
$231,683W Martin Kast · University Of Southern California · P30 · FY2022 · CA
"Modulation of Immune Checkpoints by Self-Deliverable RNAi for Adoptive Cell Transfer"
$231,500Alexey Wolfson · Advanced Rna Technologies, Llc · R43 · FY2017 · CA
BRCAL AND P21 IN CELL CYCLING
$231,466University Of Pennsylvania · R01 · FY2002 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2024 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2022 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2023 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2021 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2025 · CA
Dietary methionine restriction as a therapeutic strategy for metastatic melanoma
$231,139Isabelle Racine Miousse · University Of Arkansas At Fayetteville · P20 · FY2021 · GM
Genomics Core
$231,107Jaroslav Jelinek · Coriell Institute For Medical Research · P50 · FY2022 · CA
Genomics Core
$231,106Jaroslav Jelinek · Coriell Institute For Medical Research · P50 · FY2023 · CA
H2 haplotype and atherosclerosis
$231,000Weibin Shi · University Of Virginia · R21 · FY2012 · HL
Targeting the suppressive immune microenvironment in leptomeningeal melanoma metastases
$230,992Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2021 · CA